Wall Street News, AI generated

latest news in Biotechnology

eXoZymes Achieves Near-Perfect Efficiency in Major Manufacturing Scale-Up

eXoZymes Achieves Near-Perfect Efficiency in Major Manufacturing Scale-Up

New York, Wednesday, 18 March 2026.
eXoZymes successfully scaled its AI-enhanced enzyme technology 100-fold today, achieving a stunning 99% conversion rate. This milestone proves commercial viability, paving the way for industrial-scale biological production.

Medicus Pharma's Non-Invasive Treatment Clears 73 Percent of Skin Lesions in Latest Trial

Medicus Pharma's Non-Invasive Treatment Clears 73 Percent of Skin Lesions in Latest Trial

Toronto, Wednesday, 18 March 2026.
Medicus Pharma’s SkinJect therapy cleared 73 percent of lesions in a recent trial. This breakthrough suggests nearly three-quarters of patients might soon bypass immediate, invasive surgical interventions.

GEN Pharmaceuticals Secures Approval to Test New Parkinson's Treatment in Europe

GEN Pharmaceuticals Secures Approval to Test New Parkinson's Treatment in Europe

Amsterdam, Monday, 16 March 2026.
Securing Dutch ethical approval, GEN Pharmaceuticals will launch a Phase II trial this April for a novel drug uniquely targeting cellular energy loss to combat Parkinson’s disease.

How an Entrepreneur Used Artificial Intelligence to Build a Custom Cancer Vaccine for His Dog

How an Entrepreneur Used Artificial Intelligence to Build a Custom Cancer Vaccine for His Dog

San Francisco, Sunday, 15 March 2026.
An Australian entrepreneur bypassed traditional pharmaceutical pipelines, using consumer artificial intelligence to design a custom vaccine that successfully shrank his dying dog’s cancer tumor by half.